No Data
No Data
Med-tech and Healthcare Stocks With Upside During 2Q Earnings - Baird
Express News | Silk Road Medical Inc : Stifel Raises Target Price to $27.5 From $23
Express News | Silk Road Medical Inc : Stifel Cuts to Hold From Buy
Express News | Stifel Downgrades Silk Road Medical to Hold, Raises Price Target to $27.5
Stifel Downgrades Silk Road Medical(SILK.US) to Hold Rating, Raises Target Price to $27.5
Stifel analyst Rick Wise downgrades $Silk Road Medical(SILK.US)$ to a hold rating, and adjusts the target price from $23 to $27.5.According to TipRanks data, the analyst has a success rate of 57.9%
Argus Research Downgrades Silk Road Medical(SILK.US) to Sell Rating
Argus Research analyst David Toung downgrades $Silk Road Medical(SILK.US)$ to a sell rating.According to TipRanks data, the analyst has a success rate of 62.0% and a total average return of 9.3%
No Data
ElusiveTrader : BOE president election. they cut rates for the people . too much "economic restraint"